Pluri (NASDAQ:PLUR) Trading Down 4.5% – Should You Sell?

Shares of Pluri Inc. (NASDAQ:PLURGet Free Report) dropped 4.5% on Tuesday . The stock traded as low as $5.06 and last traded at $5.09. Approximately 40,459 shares changed hands during trading, an increase of 121% from the average daily volume of 18,346 shares. The stock had previously closed at $5.33.

Pluri Trading Down 4.5 %

The company has a debt-to-equity ratio of 4.44, a current ratio of 5.90 and a quick ratio of 5.90. The company has a market cap of $28.30 million, a PE ratio of -0.84 and a beta of 1.64. The company’s 50 day simple moving average is $5.08 and its two-hundred day simple moving average is $5.39.

Pluri (NASDAQ:PLURGet Free Report) last announced its earnings results on Wednesday, September 18th. The company reported ($2.98) earnings per share for the quarter. Pluri had a negative return on equity of 917.18% and a negative net margin of 4,184.28%. The company had revenue of $0.26 million for the quarter.

About Pluri

(Get Free Report)

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.

Featured Articles

Receive News & Ratings for Pluri Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pluri and related companies with MarketBeat.com's FREE daily email newsletter.